Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Catabasis gets initial $7.7mm in Series A round; adds $14.5mm

Executive Summary

Catabasis Pharmaceuticals Inc. (developing therapeutics for inflammatory and metabolic disorders) has raised $7.7mm out of a potential $39.7mm in its Series A financing led by SV Life Sciences, Clarus Ventures, and MedImmune Ventures, which all add a board member. Advanced Technology Ventures and 11 other investors also participated.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies

UsernamePublicRestriction

Register